August brought us exciting news from a VUB spin-off: Fertiga. The innovative VUB spin-off is thriving. They are active in the health sector and develop life-changing innovations. With this pioneering research and through the support of VUB TechTransfer, the VUB tackles today’s challenges and creates an impact on society.
One try, one child
Fertiga is a spin-off company from one of the global IVF leading centers, UZ Brussel in Belgium. UZ Brussel has been pioneering IVF, with the first ICSI baby worldwide born in 1992 from the Center of Reproductive Medicine of UZ Brussels.
Fertiga is developing the Aurora test that doubles the chances of becoming pregnant after just one fertility treatment: it improves the prediction of which egg has the highest potential for pregnancy.
“One try, one child. That should always be the goal.” – Elien Van Hecke, co-founder.
The company is currently planning a large-scale randomized clinical trial with patients from fertility centers in several different countries. The results of this study will hopefully help convince governments to make the test refundable for would-be parents.
Fertiga, a spin-off company of the Vrije Universiteit Brussel (VUB), launched an innovation last year. Their Aurora test will considerably improve the efficiency of ICSI treatments. A study with 633 patients showed that the test helped to double the pregnancy success rate of the first embryo transfer from 29 to 61 percent.